NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Withdrawn before enrolling

Conditions studied: HSV-2 Infection, Herpes Simplex Virus Infection

In brief

This study is designed to compare the performance of the NOWDx HSV-2 Test to a currently marketed device. The intent is to show the rapid test device is comparable to the currently marketed device. The NOWDx HSV-2 Test is intended for qualitatively detecting the presence or absence of human Immunoglobulin G (IgG) class antibodies to HSV-2 in human whole blood to aid in the diagnosis of infection caused by herpes simplex virus type 2 (HSV-2).

Key facts

Study ID

NCT04294030

Run by

NOWDiagnostics, Inc.

People needed

0

Starts

2023-03-01

Expected to finish

2023-10-31

Last updated by the study team

2024-02-29

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Clinical Research Consortium — Tempe, Arizona, United States
• Clinical Research of South Florida — Coral Gables, Florida, United States
• Alliance for Multispecialty Research Lexington — Lexington, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.